Neoadjuvant Chemotherapy With Cabazitaxel

Autores
Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2013
This study is aimed at evaluating the efficacy regarding the response rate and metastasis-free survival time of cabazitaxel as a neoadjuvant treatment in patients with high risk prostate cancer.
Epistemonikos ID: 3d8f2eb9368bb44459e039b429c944228a8e7638
First added on: May 11, 2024